Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
This is a multicenter, randomized, double-blind, placebo-controlled study evaluating the efficacy, safety, and tolerability of ITI-1284 compared with placebo as adjunctive therapy to GAD treatment in patients meeting Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR) criteria for GAD who have an inadequate response to ongoing GAD treatment.
Epistemonikos ID: 12d96c728c2b940c431c1f854a337c571b364c05
First added on: Jul 01, 2024